Arcus Biosciences RCUS Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arcus Biosciences's compensation and benefits?
- Arcus Biosciences (RCUS) reported compensation and benefits of $19M in Q1 2026.
- How has Arcus Biosciences's compensation and benefits changed year-over-year?
- Arcus Biosciences's compensation and benefits increased by 11.8% year-over-year, from $17M to $19M.
- What is the long-term trend for Arcus Biosciences's compensation and benefits?
- Over 3 years (2022 to 2025), Arcus Biosciences's compensation and benefits has grown at a 9.7% compound annual growth rate (CAGR), from $25M to $33M.